Status:
COMPLETED
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
Lead Sponsor:
NICHD Neonatal Research Network
Conditions:
Infant, Newborn
Infant, Low Birth Weight
Eligibility:
All Genders
Up to 6 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress ...
Detailed Description
The NICHD Neonatal Research Network conducted a randomized trial at 11 centers comparing the efficacy of two surfactants -- Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories) -...
Eligibility Criteria
Inclusion
- Newborn infants weighing 501 to 1500 gm with respiratory distress syndrome were receiving assisted ventilation with 30% oxygen or more
Exclusion
- Less than 6 hours of age
Key Trial Info
Start Date :
January 1 1991
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 1992
Estimated Enrollment :
617 Patients enrolled
Trial Details
Trial ID
NCT01203358
Start Date
January 1 1991
End Date
January 1 1992
Last Update
March 22 2019
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94304
2
Yale University
New Haven, Connecticut, United States, 06504
3
George Washington University
Washington D.C., District of Columbia, United States, 20052
4
University of Miami
Miami, Florida, United States, 33136